Spring 2019


SAVE THE DATE:
Tuesday, November 5, 2019  

 

A one-day comprehensive educational symposium on the latest developments in the diagnosis, management and treatment of COPD.

Hosted by the Temple Lung Center
Tuesday, November 5, 2019
Hilton Philadelphia City Avenue – Philadelphia, PA

ALL TOGETHER TO END COPD
A one-day comprehensive educational symposium on the latest developments in the diagnosis, management and treatment of COPD.

CONFERENCE DIRECTOR
Gerard J. Criner, MD, FACP, FACCP
Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

WHO SHOULD ATTEND

All healthcare providers involved in the care and management of patients with COPD.
This activity was planned in collaboration with the Global Initiative for Chronic Obstructive Lung Disease and the Temple Lung Center.

Registration is now open.

more >

The Future of Thoracic Surgery

Robotic systems are poised to advance thoracic surgery like never before. Many of these next steps are happening at Temple.

Pioneered in the 1980s and used commercially since the 1990s, robotic surgery is now standard of care in specialties such as urology, gynecology and colorectal surgery. Adoption has been slower in the high-acuity field of thoracic surgery—yet robotic surgery is simpler to learn than other minimally invasive techniques, and, once a surgeon develops expertise, they can operate with greater precision and several key advantages. Continue Reading >

Case Study: Bullectomy and Pleurodesis for Pneumothorax

A 53-year-old African American man with a known history of advanced pulmonary sarcoidosis, obstructive sleep apnea on CPAP and mild pulmonary hypertension, was initially evaluated for possible lung transplant. He then presented with a first episode of spontaneous left pneumothorax requiring thoracostomy tube placement. Continue Reading >

A Potential Game Changer for Treating Chronic Bronchitis

A clinical trial at the Temple Lung Center aims to treat chronic bronchitis in a completely new way, by targeting the lung cells at the root of the condition. In January, Temple performed the region’s first bronchoscopic procedure using Gala Therapeutics’ “RheOx™” device to ablate cells in the lung lining that overproduce mucus in a patient with chronic bronchitis. Continue Reading >

Quercetin for Chronic Obstructive Pulmonary Disease

Studies at the Lewis Katz School of Medicine and the Temple Lung Center are examining potential treatments for chronic obstructive pulmonary disease (COPD) based on the naturally occurring polyphenol quercetin. COPD is the third-leading cause of death in the United States; at present, there is no cure. Continue Reading >

FDA Approves Second Endobronchial Valve Treatment for Emphysema

The December 2018 announcement of FDA approval on the Olympus Spiration® Valve System (SVS) means patients now have a second option for minimally invasive endobronchial valve treatment for severe emphysema. The Spiration® Valve System was granted priority review status and approval under the FDA’s breakthrough medical devices designation. Continue Reading >